Vaccines

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

Ottawa - Short-term thinking about influenza infection limits the illness to the acute period of illness when in fact, functional decline following hospitalization for influenza can be persistent and life-altering. Among the well, vaccine...

Vancouver - Uptake of the seasonal influenza vaccine is far from optimal in pediatric practice and physicians have an important role to play in helping parents understand why influenza vaccination is critical for infants and young children....

Travellers’ diarrhea affects approximately half of those who travel to low- and middle-income countries. While often self-limiting, up to half of travellers who acquire travellers’ diarrhea will be inconvenienced by the...

Toronto - Invasive meningococcal disease (IMD) is a rare but catastrophic disease associated with high morbidity and mortality rates. Today by far and away the greatest proportion of IMD in Canada is caused by Neisseria meningitidis...

Toronto - A new 9-valent vaccine against the human papilloma virus (HPV) has recently been approved by Health Canada and is indicated for use in young girls and women between 9 and 45 years of age as well as in boys and men between 9 and 26...

Ottawa - Elderly patients are at high risk for developing influenza and its complications, which can include increased frailty after hospitalization. Immunization in this population is vital, despite the fact that immune senescence lowers...

Ottawa – The burden of illness associated with influenza infection is considerable, and it is particularly pronounced in the very young and in the elderly. Both groups respond less than optimally to standard influenza vaccines and...

Ottawa – Of the 5 serogroups responsible for invasive meningococcal disease (IMD), serogroup B is by far the most common in Canada today. IMD also disproportionately affects young infants with another peak in incidence in...

Ottawa - Primary care providers are required to answer three questions for patients when they come asking about the human papilloma virus (HPV) vaccine: Is it safe? Does it work? And what do you think about it? Providing good,...

Quebec City - Invasive meningococcal disease (IMD) caused by serogroup B Neisseria meningitidis is the most common IMD in Canada today. The incidence of serogroup B disease is also highest in infants under the age of 12 months, children...